Osteogenic differentiation of bone marrow mesenchymal stem cells by adenovirus-mediated expression of leptin

Regulatory Peptides

Volumn 163, Issue 1-3, 2010, Pages 107-112

  Han, Guosheng ^a   Jing, Yingying ^b   Zhang, Yuhui ^a   Yue, Zhijian ^a   Hu, Xiaowu ^a   Wang, Laixing ^a   Liang, Jinchuan ^a   Liu, Jianmin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Leptin; Mesenchymal stem cells; Osteogenic differentiation

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; CORE BINDING FACTOR BETA; LEPTIN; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC ENGINEERING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; NORMAL HUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADENOVIRIDAE; ALKALINE PHOSPHATASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; LEPTIN; MESENCHYMAL STEM CELLS; OSTEOCALCIN; RECOMBINANT FUSION PROTEINS; UP-REGULATION;

ADENOVIRIDAE;

EID: 77953914437     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.04.006     Document Type: Article

References (29)

1. Pittenger M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
2. Qu-Petersen Z., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002, 157(5):851-864.
3. Zuk P.A., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13(12):4279-4295.
4. Yoo J.U., Johnstone B. The role of osteochondral progenitor cells in fracture repair. Clin Orthop Relat Res 1998, 355 Suppl:S73-S81.
5. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000, 28(8):875-884.
6. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276(5309):71-74.
7. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2(1):35-43.
8. Zhang Y., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372(6505):425-432.
9. Ducy P., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100(2):197-207.
10. Aleffi S., et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005, 42(6):1339-1348.
11. Ben Hamouda K., et al. Thoracic myelopathy caused by ossification of the ligamentum flavum: a report of 18 cases. J Neurosurg 2003, 99(2 Suppl):157-161.
12. Zhang F., et al. Leptin: structure, function and biology. Vitam Horm 2005, 71:345-372.
13. Thomas T., et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140(4):1630-1638.
14. Majumdar M.K., et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998, 176(1):57-66.
15. Phinney D.G. Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl 2002, 38:7-12.
16. Dhillon H., et al. Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship Body Weight Change Regul Pept 2000, 92(1-3):97-105.
17. Dhillon H., Kalra S.P., Kalra P.S. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther 2001, 4(2):139-145.
18. Dhillon H., et al. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept 2001, 99(2-3):69-77.
19. Dube M.G., et al. Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels. Diabetes 2002, 51(6):1729-1736.
20. Mehlhorn A.T., et al. Mesenchymal stem cells maintain TGF-beta-mediated chondrogenic phenotype in alginate bead culture. Tissue Eng 2006, 12(6):1393-1403.
21. Xie Y., et al. Recombinant human IL-24 suppresses lung carcinoma cell growth via induction of cell apoptosis and inhibition of tumor angiogenesis. Cancer Biother Radiopharm 2008, 23(3):310-320.
22. Conget P.A., Minguell J.J. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol 2000, 28(4):382-390.
23. Marion N.W., Mao J.J. Mesenchymal stem cells and tissue engineering. Methods Enzymol 2006, 420:339-361.
24. Jager M., et al. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Ann Biomed Eng 2005, 33(10):1319-1332.
25. Rodriguez J.P., et al. Cytoskeletal organization of human mesenchymal stem cells (MSC) changes during their osteogenic differentiation. J Cell Biochem 2004, 93(4):721-731.
26. Reseland J.E., et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001, 16(8):1426-1433.
27. Gordeladze J.O., et al. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 2002, 85(4):825-836.
28. Hess R., et al. High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors. J Cell Biochem 2005, 94(1):50-57.
29. Toma C., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105(1):93-98.